Moisand Fitzgerald Tamayo, LLC Charles River Laboratories International, Inc. Transaction History

Moisand Fitzgerald Tamayo, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 12, 2023	SELL	$183.71 - $210.25 $734 - $841	-4 Reduced 33.33%	8 $1,000
Q1 2023 May 05, 2023	BUY	$191.89 - $259.92 $767 - $1,039	4 Added 50.0%	12 $2,000
Q4 2022 Jan 23, 2023	BUY	$197.11 - $250.07 $591 - $750	3 Added 60.0%	8 $0
Q3 2022 Oct 26, 2022	SELL	$182.44 - $250.54 $1,824 - $2,505	-10 Reduced 66.67%	5 $1,000
Q2 2022 Aug 01, 2022	SELL	$204.13 - $302.4 $1,020 - $1,512	-5 Reduced 25.0%	15 $3,000
Q1 2022 Apr 29, 2022	BUY	$255.51 - $362.11 $5,110 - $7,242	20 New	20 $6,000

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.56B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Moisand Fitzgerald Tamayo, LLC, based on Form 13F filings with the SEC.

Stay updated on Moisand Fitzgerald Tamayo, LLC with notifications on news.